BioCentury
ARTICLE | Politics & Policy

Sanford-Burnham names Nisen CEO

August 20, 2014 1:47 AM UTC

Sanford-Burnham Medical Research Institute named Perry Nisen CEO, effective Sept. 15. Nisen was SVP of science and innovation at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). He replaces John Reed, who joined Roche (SIX:ROG; OTCQX:RHHBY) in January 2013. Sanford-Burnham President Kristiina Vuori served as interim CEO of the institute. ...